Endo International – Recall of Robaxin® (methocarbamol)
September 28, 2018 - Endo Pharmaceuticals announced a voluntary consumer-level recall of two lots of Robaxin (methocarbamol) 750 mg tablets because the products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily."
Top